Information Driven Collaborative
Chemistry
Put
Tripos Expertise to Work for You
For over 20
years, Tripos has built a reputation in innovation
and leadership by analyzing chemical data and and
providing smart solutions, which solve real
problems for real chemists. Now Tripos provides
another smart solution: a uniquely intelligent,
proprietary discovery chemistry process that can
cut your Hit-Finding to lead optimization
development time 30 - 50%.
This chemical
technology is built around integrated informatics,
bringing together biological and chemical data,
capturing and utilizing chemical knowledge, and
analyzing it efficiently. This information-driven
process provides analytical knowledge that leads to
improved critical decision-making, therefore moving
your projects quickly to completion or terminating
non-viable projects rapidly.
Screening-Ready Set 03:12 -
Aminergic GPCR Targeted Set - structurally diverse,
target-focused compounds designed for efficient
lead discovery in aminergic GPCR and related target
programs.
LeadQuest®- a library of 80,000
compounds, designed for novelty, drug-likeness, and
high purity, which can be cherry picked.
LeadScreen - a pre-selected,
pre-plated collection of 50,000 compounds.
Collaborative chemistry expertise
ready to help you get to the next step in your
research project
LeadFocus - rapidly generate a
focused analog library around your hitfor
validation and SAR development.
LeadHopping - rapidly generate a
library of structurally distinct compounds around a
given lead compound to move forward around patent,
ADME/Tox or synthetic accessibility problems.
Tripos proven
informatics driven chemistry process has
accelerated discovery projects irrespective of
starting point. This proprietary process has
resulted in lead candidates that are currently the
subject of patent applications, and in one
instance, an optimized, patentable set of lead
series compounds was created in only 8 months,
including screening.
Customers
include Pfizer, Lipha, Arena Pharmaceuticals,
Signase, BMS, Wolfson, Arrow Therapeutics and many
others.
|